MedNet.nl: Following positive study results, real-world data from 23,442 patients also show that with semaglutide, improvements in weight and HbA1c persisted over a 3-year period. Improvements in HbA1c and weight were more pronounced in patients with greater adherence to treatment.
10-10-2023 | Type 2 Diabetes | News